Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development
Go back to Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development| (NASDAQ: AUTL) | Delayed: 1.49 -0.02 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.51 | 52 Week High | $ | |||
| Open | $1.52 | 52 Week Low | $ | |||
| Day High | $1.57 | P/E | N/A | |||
| Day Low | $1.49 | EPS | $ | |||
| Volume | 532,189 | |||||
